Long-term Ciclosporin Treatment in Children with Steroid-dependent Nephrotic Syndrome

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 1993 Jun 1

PMID 8518091

Citations 10

Authors

R Tanaka

N Yoshikawa

Y Kitano

H Ito

H Nakamura

Affiliations

Soon will be listed here.

Abstract

We report the effect of 18-month ciclosporin (CS) treatment in 19 children with steroid-dependent frequently relapsing nephrotic syndrome. CS was started at 3-5 mg/kg per day after remission with steroid therapy, was adjusted to maintain a trough blood level of between 200 and 600 ng/ml and was administered for 6 months (high-dose CS). Then, the dosage of CS was decreased and 2.5 mg/kg per day was administered for the subsequent 12 months (low-dose CS). Only 2 patients had relapses during the initial 6 months of CS therapy. Eight patients had infrequent relapses, 4 had frequent relapses and 7 had no relapses during the 12 months of low-dose CS. Not only did continuation of CS at a lower dosage decrease the relapse rate, it also reduced steroid toxicity, allowed increased growth in 16 of the 19 patients and also decreased obesity scores in 12 of these patients. All of the side-effects that occurred during the 18-month period of CS treatment were reversible and none was serious enough to necessitate discontinuation of therapy. Our 18-month CS treatment was helpful in preventing relapses and reducing steroid toxicity in children with steroid-dependent frequently relapsing nephrotic syndrome.

Citing Articles

Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome.

Robinson C, Aman N, Banh T, Brooke J, Chanchlani R, Cuthbertson B JAMA Pediatr. 2025; 179(3):321-331.

PMID: 39869322 PMC: 11773402. DOI: 10.1001/jamapediatrics.2024.5286.

Cyclosporin population pharmacokinetics in pediatric refractory nephrotic syndrome based on real-world studies: Effects of body weight and spirolactone administration.

Wang D, Chen X, Li Z Exp Ther Med. 2019; 17(4):3015-3020.

PMID: 30936972 PMC: 6434233. DOI: 10.3892/etm.2019.7325.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy.

Ishikura K, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K Clin Exp Nephrol. 2015; 19(1):6-33.

PMID: 25653046 DOI: 10.1007/s10157-014-1030-x.

Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.

Iijima K, Sako M, Oba M, Ito S, Hataya H, Tanaka R Clin J Am Soc Nephrol. 2013; 9(2):271-8.

PMID: 24262503 PMC: 3913253. DOI: 10.2215/CJN.13071212.

Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children.

Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K Clin J Am Soc Nephrol. 2012; 7(10):1576-83.

PMID: 22837276 PMC: 3463200. DOI: 10.2215/CJN.00110112.

References

Garin E, Pryor N, Fennell 3rd R, RICHARD G . Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. J Pediatr. 1978; 92(2):304-8. DOI: 10.1016/s0022-3476(78)80032-8. View

. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie. Arch Dis Child. 1987; 62(11):1102-6. PMC: 1778533. DOI: 10.1136/adc.62.11.1102. View

. Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children. J Pediatr. 1982; 101(4):514-8. DOI: 10.1016/s0022-3476(82)80692-6. View

Brandis M, Burghard R, Leititis J, Zimmerhackl B, Hildebrandt F, Helmchen U . Cyclosporine A for treatment of nephrotic syndromes. Transplant Proc. 1988; 20(3 Suppl 4):275-9. View

Niaudet P . Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol. 1992; 6(1):1-3. DOI: 10.1007/BF00856817. View

BRODEHL J, Hoyer P, Oemar B, Helmchen U, Wonigeit K . Cyclosporine treatment of nephrotic syndrome in children. Transplant Proc. 1988; 20(3 Suppl 4):269-74. View

. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int. 1981; 20(6):765-71. DOI: 10.1038/ki.1981.209. View

Kitano Y, Yoshikawa N, Tanaka R, Nakamura H, Ninomiya M, Ito H . Ciclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 1990; 4(5):474-7. DOI: 10.1007/BF00869823. View

Niaudet P, Tete M, Broyer M, Habib R . Cyclosporine and childhood idiopathic nephrosis. Transplant Proc. 1988; 20(3 Suppl 4):265-8. View

10.

. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med. 1982; 306(8):451-4. DOI: 10.1056/NEJM198202253060803. View

11.

Capodicasa G, De Santo N, Nuzzi F, Giordano C . Cyclosporin A in nephrotic syndrome of childhood--a 14 month experience. Int J Pediatr Nephrol. 1986; 7(2):69-72. View

12.

Hoyer P, Krull F, BRODEHL J . Cyclosporin in frequently relapsing minimal change nephrotic syndrome. Lancet. 1986; 2(8502):335. DOI: 10.1016/s0140-6736(86)90017-6. View

13.

Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal C, Khawar M . Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int. 1988; 33(3):729-34. DOI: 10.1038/ki.1988.59. View